Naloxone & Alternative Opioid Antagonists - Buffer Stock Storage & Management

Concepts

• pharmaceutical products
• opioids
• naloxone
• naloxone and potential alternative opioid antagonists
• management
• buffer stock
• opioid antagonists - buffer stock storage
• stock
• buffer
• opioid

Location

London

Description

Market engagement exercise to assess the current and future capacity of the UK market to provide naloxone and potential alternative opioid antagonists.

Total Quantity or Scope

DHSC is conducting a market engagement exercise to understand more about the companies and services in the UK that can, or that are seeking to produce, distribute, supply and store different formulations of naloxone and of other drugs that can reverse the effect of an opioid overdose or of drugs taken with opioids.The outcome of the market engagement will inform decisions around potential future procurement and storage of buffer stock as well as providing information on how the market could meet a potential increase in demand across the UK.

CPV Codes

• 33600000 - Pharmaceutical products
• 33670000 - Medicinal products for the respiratory system

Indicators

Other Information

For avoidance of doubt this is not a call for competition, the purpose is to seek feedback from the market that may inform the final specification and/or procurement approach to the goods and services.It is essential to understand that this market engagement process is separate from the formal procurement process. When the formal procurement process begins through the publication of a contract notice, any supplier interested in the contractual opportunity must submit a tender, and all supplier bids will be evaluated on an equal basis and in accordance with the set criteria. The market engagement brief and associated questionnaire can be found here: https://www.contractsfinder.service.gov.uk/Notice/b702d08b-f9d2-4f4b-8324-726e54...